However, most other Tg or KI mouse lines expressing pathogenic LRRK2 mutants under different promoter systems do not exhibit synucleinopathy, which may be in part explained by the insufficient amount of seeds required for α-synuclein aggregation. Here, LRRK2 is linked to synucleinopathy.